Biodesix is a molecular diagnostics company specializing in the development and commercialization of blood-based diagnostic tests that support the clinical decision-making process for respiratory diseases and cancer. Leveraging its proprietary AI-driven diagnostic platform, Biodesix offers a suite of precision medicine solutions aimed at improving patient outcomes and optimizing healthcare strategies. Their innovative approach focuses on non-invasive testing to provide actionable insights enabling more personalized and effective treatment plans.